查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511857

华盛顿州合法大麻市场规模、份额和趋势分析报告：按来源、衍生物、按最终用途、细分市场预测，2024-2030 年

Washington Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By End-use (Industrial Use, Medical Use), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

华盛顿州合法大麻市场成长与趋势

Grand View Research, Inc.的最新报告显示，到2030年，华盛顿州合法大麻市场规模预计将达到33.4亿美元，2024年至2030年的复合年增长率为14.4%。消费者可支配收入增加、药用大麻合法化、消费者对大麻健康益处的认识不断增强、製药业对大麻的需求增加以及美国农业法案的核准等因素预计将推动市场成长。

大麻广泛用于治疗各种健康状况，包括癌症、精神疾病、疼痛和噁心，以及用于娱乐目的。在预测期内，癌症发生率的增加预计将极大促进医用大麻的接受度不断提高。例如，根据美国癌症协会2023年1月发表的报导，预计2023年美国将有609,820人死于癌症，并且将有1,958,310人新诊断出患有癌症。在美国，两种CBD药物（大麻龙和屈大麻酚）已被FDA核准用于治疗化疗引起的噁心和呕吐。

此外，大麻认证计划的数量不断增加以及人们对大麻治疗功效的认识不断提高正在推动市场成长。例如，华盛顿州塔科马社区学院提供为期九週的线上认证计划，帮助学生了解大麻供应链并培养在大麻种植环境中蓬勃发展所需的技能。此外，对各种含有 CBD 的产品的需求不断增长，包括饮料、大麻油、美容产品、胶囊和软糖。让 CBD 进入体内的方法有很多，包括电子烟、吸烟和局部使用。大麻已在华盛顿州合法化，CBD 正用于个人保健产品和药物的开发。大麻产品的合法化为各行业扩大产品范围创造了巨大的扩张机会。

此外，大麻种植的新技术和改进也在不断开发。随着对技术先进的大麻生产的需求不断增加，这些增强的技术预计将帮助种植者优化资源并进一步推动市场成长。

华盛顿合法大麻市场报告亮点

  • 从来源来看，由于人们对大麻用于医疗目的的认识提高以及对其治疗效果的研究增加，大麻产业在 2023 年的销售额中占据最大份额。
  • 从衍生性商品来看，由于对含有 CBD 的食品、化妆品和药品的需求增加，CBD 产业在 2023 年占据了最大的销售份额。
  • 按最终用途划分，由于吸烟和食用大麻的需求不断增长，娱乐用途细分市场在 2023 年占据最大的市场占有率。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章华盛顿州合法大麻市场的变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 案例研究分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
  • 监管状况

第 4 章 2018-2030 年华盛顿州合法大麻市场細項分析（按来源）

  • 定义和范围
  • 源细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • 大麻
    • 2018-2030 年市场估计与预测
    • 大麻CBD
    • 工业大麻
  • 大麻
    • 2018-2030 年市场估计与预测
    • 花
    • 油和酊剂

第 5 章. 华盛顿州合法大麻市场細項分析（按衍生物），2018-2030

  • 定义和范围
  • 衍生物细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • CBD
    • 2018-2030 年市场估计与预测
  • THC
    • 2018-2030 年市场估计与预测
  • 其他的
    • 2018-2030 年市场估计与预测

第 6 章：2018-2030 年华盛顿州合法大麻市场細項分析（按最终用途）

  • 定义和范围
  • 最终用途细分仪表板
  • 2018-2030年市场规模、预测及趋势分析
  • 工业用途
    • 2018-2030 年市场估计与预测
  • 医疗用途
    • 2018-2030 年市场估计与预测
    • 慢性疼痛
    • 忧郁症和焦虑
    • 关节炎
    • 创伤后压力症候群（PTSD）
    • 癌症
    • 偏头痛
    • 癫痫
    • 阿兹海默症
    • 多发性硬化症
    • 肌萎缩侧索硬化症
    • 妥瑞症
    • 糖尿病
    • 帕金森氏症
    • 青光眼
    • 其他的
  • 休閒用途
    • 2018-2030 年市场估计与预测

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司市场分析
  • 公司简介
    • NORTHWEST CANNABIS SOLUTIONS
    • The Hollingsworth Cannabis Company, LLC
    • Alkaloid Cannabis Company
    • Herbs House
    • Nirvana Cannabis
    • Edgemont Group（Leafwerx）
    • OLYMPIA WEED COMPANY
    • Canna West Seattle
    • Grow Op Farms（Phat Panda）
    • Forbidden Farms, LLC
Product Code: GVR-4-68040-306-0

Washington Legal Cannabis Market Growth & Trends:

The Washington legal cannabis market size is expected to reach USD 3.34 billion by 2030, registering a CAGR of 14.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as growing consumer disposable income, legalization of medicinal cannabis, growing consumer awareness of the health benefits of cannabis, increasing demand for cannabis from the pharmaceutical industry, and the approval of the U.S. Farm Bill are expected to boost the market growth.

Cannabis is widely utilized for managing a range of health conditions, including cancer, mental health issues, pain, and nausea, and for recreational purposes. The growing incidence of cancer is anticipated to significantly contribute to the growing acceptance of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were projected to occur in the U.S. in 2023. In the U.S., two CBD drugs (nabilone and dronabinol) are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy.

In addition, the rise in cannabis certification programs and growing awareness among people regarding the therapeutic benefits of cannabis boosts market growth. For instance, Washington-based Tacoma Community College offers a 9-week online certificate program that gives an understanding of the cannabis supply chain and the skills needed to excel in the cannabis cultivation environment. Moreover, there is a growing demand for various CBD-infused products, such as beverages, cannabis oil, beauty products, capsules, gummies, etc. Various methods, such as vaping, smoking, or topical application, can introduce CBD into the body. In Washington, cannabis is legal, and CBD is employed to develop personal care products and medicinal products. The legalization of cannabis-based products created significant expansion opportunities for various industries to broaden their range of products.

Furthermore, new technologies and improvements are continually being developed for cannabis cultivation. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, further driving the market's growth.

Washington Legal Cannabis Market Report Highlights:

  • By source, the marijuana segment accounted for the largest revenue share in 2023, owing to the recognition of cannabis for medical purposes and growing research studies for its therapeutic benefits
  • By derivatives, the CBD segment dominated the market with the largest revenue share in 2023, due to rise in demand for CBD-infused food, cosmetics, and medication
  • By end use, the recreational use segment held the largest market share in 2023 due to the growing demand for cannabis for smoking and consuming it in the form of foods & beverage

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Source
    • 1.2.2. Derivatives
    • 1.2.3. End-use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Source outlook
    • 2.2.2. Derivatives outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Washington Legal Cannabis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Case Study Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
  • 3.4. Regulatory Landscape

Chapter 4. Washington Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Source Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4. Hemp
    • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hemp CBD
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Industrial Hemp
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Marijuana
    • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Flower
      • 4.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Oil and Tinctures
      • 4.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Washington Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Derivatives Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4. CBD
    • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. THC
    • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Washington Legal Cannabis Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End-use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4. Industrial Use
    • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Medical Use
    • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Chronic Pain
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Depression and Anxiety
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Arthritis
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Post-traumatic Stress Disorder (PTSD)
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Cancer
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Migraines
      • 6.5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Epilepsy
      • 6.5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Alzheimer's
      • 6.5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Multiple Sclerosis
      • 6.5.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.11. Amyotrophic Lateral Sclerosis
      • 6.5.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.12. Tourette's
      • 6.5.12.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.13. Diabetes
      • 6.5.13.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.14. Parkinson's
      • 6.5.14.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.15. Glaucoma
      • 6.5.15.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.16. Others
      • 6.5.16.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Recreational Use
    • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Position Analysis
  • 7.4. Company Profiles
    • 7.4.1. NORTHWEST CANNABIS SOLUTIONS
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Service Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. The Hollingsworth Cannabis Company, LLC
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Service Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Alkaloid Cannabis Company
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Service Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Herbs House
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Service Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Nirvana Cannabis
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Service Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Edgemont Group (Leafwerx)
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Service Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. OLYMPIA WEED COMPANY
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Service Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Canna West Seattle
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Service Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Grow Op Farms (Phat Panda)
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Service Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Forbidden Farms, LLC
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Service Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Washington legal cannabis market, by source, 2018 - 2030 (USD Million)
  • Table 4 Washington legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
  • Table 5 Washington legal cannabis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Value-chain-based sizing & forecasting
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market research approaches
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. cannabis market: market outlook
  • Fig. 9 U.S. cannabis competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Washington legal cannabis market driver impact
  • Fig. 14 Washington legal cannabis market restraint impact
  • Fig. 15 Washington legal cannabis market: Source movement analysis
  • Fig. 16 Washington legal cannabis market: Source outlook and key takeaways
  • Fig. 17 Hemp market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Hemp CBD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Industrial hemp market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Flower market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Oil and tinctures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Washington legal cannabis market: Derivatives movement analysis
  • Fig. 24 Washington legal cannabis market: Derivatives outlook and key takeaways
  • Fig. 25 CBD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 THC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Washington legal cannabis market: End-use movement analysis
  • Fig. 29 Washington legal cannabis market: End-use outlook and key takeaways
  • Fig. 30 Industrial use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Medical use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Chronic pain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Depression and anxiety market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Arthritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Post-traumatic stress disorder (PTSD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Migraines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Epilepsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Alzheimer's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Multiple sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 AIDS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Amyotrophic lateral sclerosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Tourette's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Parkinson's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Glaucoma market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Recreational Use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key company categorization